Determining the role of Xpert® MTB/RIF in diagnosing tuberculosis in postmortem tissues

Alberto Garcia-Basteiro (Maputo, Mozambique), Alberto García-Basteiro, Mamudo Ismail, Carla Carrilho, Esperança Ussene, Paola Castillo, Dercio Chitsungo, Lucilia Lovene, Cesaltina Lorenzoni, Cristina Rodríguez, Jordi Vila, Jaume Ordi, Clara Mendendez, Quique Bassat, Miguel Martínez

Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Session: WHO guidelines in TB and clinical practice
Session type: Poster Discussion
Number: 1532
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Alberto Garcia-Basteiro (Maputo, Mozambique), Alberto García-Basteiro, Mamudo Ismail, Carla Carrilho, Esperança Ussene, Paola Castillo, Dercio Chitsungo, Lucilia Lovene, Cesaltina Lorenzoni, Cristina Rodríguez, Jordi Vila, Jaume Ordi, Clara Mendendez, Quique Bassat, Miguel Martínez. Determining the role of Xpert® MTB/RIF in diagnosing tuberculosis in postmortem tissues. Eur Respir J 2015; 46: Suppl. 59, 1532

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Xpert MTB/RIF testing of pooled induced sputum
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014

Estimation of the role of the test GeneXpert MTB-RIF in the diagnosis of pulmonary tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014

Role of GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampacin(R) resistance in patients in high risk DRTB
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014

Clinical utility of the Xpert MTB/RIF test in induced sputum
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015


A comparison between the efficiency of the Xpert MTB/RIF assay and nested PCR in identifying mycobacterium tuberculosis during routine clinical practice
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014

Influence of early diagnostics with Xpert MTB/RIF on MDR TB patients treatment efficacy
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015

Comparative study of gene Xpert MTB/RIF, smear microscopy and TB MGIT culture in diagnosis of tuberculosis in India
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015


Tuberculosis diagnosis in rural Namibia using gene Xpert MTB/RIF testing
Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR
Year: 2016

Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis
Source: Eur Respir J 2012; 40: 442-447
Year: 2012



Early tuberculosis treatment monitoring by Xpert® MTB/RIF
Source: Eur Respir J 2012; 39: 1269-1271
Year: 2012


Detection of TB by smear microscopy and GeneXpert MTB/RIF assay in non expectorating pulmonary TB suspects and pleural TB in high prevalent low income setting
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014

Utility of Xpert® MTB/RIF assay for extrapulmonary tuberculosis, a two year study
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019


Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis
Source: Eur Respir J 2013; 42: 708-720
Year: 2013



Factors that predict for positive GeneXpert MTB/RIF on bronchoalveolar lavage samples in children with suspected tuberculosis
Source: International Congress 2014 – Paediatric bronchology
Year: 2014



Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting?
Source: Eur Respir J 2012; 40: 161-168
Year: 2012



Performance of Xpert MTB/RIF Ultra for tuberculosis diagnosis in the context of passive and active case finding
Source: Eur Respir J, 58 (6) 2100257; 10.1183/13993003.00257-2021
Year: 2021



Evaluation of Xpert MTB/RIF assay performance in diagnosing extrapulmonary tuberculosis among adults in a tertiary care centre in India
Source: Eur Respir J 2014; 44: 1090-1093
Year: 2014


Diagnostic yield of AFB smear, culture, LiPA, GeneXpert: A clinician’s perspective
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015


Effect of history of tuberculosis on specificity of Xpert MTB/RIF
Source: Eur Respir J, 56 (3) 2000343; 10.1183/13993003.00343-2020
Year: 2020



Incremental Yield of Xpert MTB/RIF Ultra over Xpert MTB/RIF in the diagnosis of extra-pulmonary tuberculosis
Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis
Year: 2020